Elevance Health Inc
$ 344.76
-0.44%
24 Apr - close price
- Market Cap 74,868,908,000 USD
- Current Price $ 344.76
- High / Low $ 350.79 / 342.75
- Stock P/E 14.60
- Book Value 198.81
- EPS 23.62
- Next Earning Report 2026-07-16
- Dividend Per Share $6.85
- Dividend Yield 1.98 %
- Next Dividend Date -
- ROA 0.04 %
- ROE 0.12 %
- 52 Week High 418.60
- 52 Week Low 269.17
About
Elevance Health Inc. is a health benefits company. The company is headquartered in Indianapolis, Indiana.
Analyst Target Price
$382.19
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-04-22 | 2026-01-28 | 2025-10-21 | 2025-07-17 | 2025-04-22 | 2025-01-23 | 2024-10-17 | 2024-07-17 | 2024-04-18 | 2024-01-24 | 2023-10-18 | 2023-07-19 |
| Reported EPS | 12.58 | 3.33 | 6.03 | 8.84 | 11.97 | 3.84 | 8.37 | 10.12 | 10.64 | 5.62 | 8.99 | 9.04 |
| Estimated EPS | 10.81 | 3.09 | 4.94 | 8.96 | 11.48 | 3.85 | 9.65 | 10.01 | 10.53 | 5.59 | 8.46 | 8.78 |
| Surprise | 1.77 | 0.24 | 1.09 | -0.12 | 0.49 | -0.01 | -1.28 | 0.11 | 0.11 | 0.03 | 0.53 | 0.26 |
| Surprise Percentage | 16.3737% | 7.767% | 22.0648% | -1.3393% | 4.2683% | -0.2597% | -13.2642% | 1.0989% | 1.0446% | 0.5367% | 6.2648% | 2.9613% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-07-16 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 6.29 |
| Currency | USD |
Previous Dividend Records
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-06-25 | 2026-03-25 | 2025-12-19 | 2025-09-25 | 2025-06-25 | 2025-03-25 | 2024-12-20 | 2024-09-25 | 2024-06-25 | 2024-03-22 |
| Amount | $1.72 | $1.72 | $1.71 | $1.71 | $1.71 | $1.71 | $1.63 | $1.63 | $1.63 | $1.63 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: ELV
2026-04-25 12:50:30
Polaris Capital Management LLC reduced its stake in Elevance Health (NYSE:ELV) by 11.9% in the fourth quarter, selling 10,000 shares and leaving it with 73,941 shares valued at $25.92 million. Despite this trimming, Elevance Health constitutes 2.2% of Polaris Capital Management's holdings. The article also highlights Elevance Health's strong Q1 earnings, exceeding analyst expectations, and an increased 2026 adjusted EPS outlook, though the company faces an investor securities probe.
2026-04-25 11:54:29
Solidarity Wealth LLC has acquired 4,087 shares of Elevance Health, Inc. (NYSE:ELV) worth approximately $1.43 million in the fourth quarter. This acquisition comes as Elevance Health reported strong Q1 results, exceeding EPS estimates, and raised its 2026 adjusted EPS outlook. Despite mixed analyst responses with price targets varying, the company's stock currently holds a "Hold" consensus rating.
2026-04-25 09:08:29
Coronation Fund Managers Ltd. increased its stake in Elevance Health, Inc. by 24.9% in the fourth quarter, now owning 159,249 shares valued at approximately $55.8 million. This makes Elevance Health its 11th-largest holding. The company reported strong Q1 results, beating EPS estimates, and raised its 2026 adjusted EPS outlook, although it faces an investor litigation probe.
2026-04-24 20:14:42
Humana Inc. (HUM) recently held its annual shareholder meeting, announcing a US$2.14 billion ESOP-related shelf registration, an affirmed quarterly dividend, and the election of Robert S. Field to its board. Concurrently, its CenterWell subsidiary launched a 72-indicator Fulfillment Index aimed at comprehensively measuring senior well-being beyond standard clinical metrics. These developments suggest a dual focus for Humana on robust governance and workforce incentives, alongside a broader, more holistic approach to senior health.
2026-04-24 18:37:29
GuruFocus provides a detailed overview of Elevance Health Inc (ELV), a leading US health insurer. The article includes real-time stock data, financial strength indicators, growth ranks, profitability metrics, and a summary of recent news and analyst estimates. Notably, it highlights ELV's strong market position due to its Blue Cross Blue Shield affiliation and its expanding presence in government-sponsored programs and healthcare services.
2026-04-24 13:33:30
Elevance Health (ELV) reported strong first-quarter 2026 results, surpassing Wall Street expectations with adjusted diluted EPS of $12.58, significantly beating the $10.82 consensus. This outperformance led to a stock increase and a raised full-year 2026 adjusted diluted EPS guidance to at least $26.75, confirming 2026 as a trough year before a projected 12% EPS growth in 2027. Despite some ongoing challenges in Medicaid margins and a CMS accrual, analysts maintain a positive outlook, seeing the stock as undervalued given its recovery trajectory.
